학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 166,540건 | 목록
1~20
Academic Journal
Academic Journal
Alexescu, Teodora Gabriela; Lungu, Denisa; Popescu, Tania; Perne, Mirela Georgiana; Gerdanovics, Cezara Andreea; Orășan, Olga Hilda; Cozma, Angela; Dobrotă, Ioana Raluca; Togănel, Răzvan Dan; Milaciu, Mircea Vasile; Ciumărnean, Lorena; Leach, Nicoleta Valentina; Vlad, Călin Vasile; Zolog, Vlad Alexandru; Cheregi, Cornel Dragoș
Academic Journal
Die Onkologie: Organ der Deutschen Krebsgesellschaft e.V.. 30(9):863-872
Academic Journal
Wealther, Ryan H.; Verma, Kritin K.; Matthew, Ethan; Chen, Helen; Stetson, Cloyce; Bassukas, Ioannis D.
Academic Journal
Vaidya, Poorva; Wu, Sharon; Bryant, Dave; Perry, Curtis J.; Prakash, Varsha; Lou, Emil; Guo, Theresa; Brownell, Isaac; Darabi, Sourat; Gao, Ling; Abdulla, Farah; Park, Soo J.
Academic Journal
Dingley, Brittany; Delisle, Megan; Light, Anne; Apte, Sameer; Mallick, Ranjeeta; Hamilton, Trevor; Stuart, Heather; Talbot, Martha; McKinnon, Gregory; Jost, Evan; Thiboutot, Eva; Francescutti, Valerie; Samman, Salsabila; Easson, Alexandra M.; Schellenberg, Angela; Merchant, Shaila; La, Julie; Vanderbeck, Kaitlin; Wright, Frances C.; Berger-Richardson, David
Academic Journal
Recalde Vizcay, Enar; Navalpotro Yagüe, Begoña; Ferrandiz-Pulido, Carla; Hernando Cubero, Jorge; Capdevila, Jaume; Peregrin Pastor, Blanca; Granado Carrasco, Raquel
Clinical and Translational Oncology. 28(1):366-373
Academic Journal
Academic Journal
Lei, KC; Srinivas, N; Chandra, M; Serobyan, V; Ugurel, S; Hoffmann, D; Kervarrec, T; Lui, W-O; Becker, JC
ONCOGENE. 44(47):4615-4625
Academic Journal
Shi, H; Yang, Y; Gao, J; Kumar, S; Xie, H; Chen, Z; Lyu, J; Sihto, H; Koljonen, V; Vega-Rubin-de-Celis, S
AUTOPHAGY. 21(7):1523-1543
Academic Journal
Sharma, Jagdeep; Walia, Harsimran Singh; Saini, Varun; Guru, Arvind; Mitra, Lalita Gouri; Gulia, Ashish
Academic Journal
Janik, Stefan; Pammer, Johannes; Simader, Elisabeth; Kotowski, Ulana; Grasl, Stefan; Houben, Roland; Copic, Dragan; Mildner, Michael; Mitulovic, Goran; Bilban, Martin; Derdak, Sophia; Unterwurzacher, Markus; Kratochwill, Klaus; Erovic, Boban M.
Academic Journal
Tai, Patricia; Alqaisi, Omar; Al-Ghabeesh, Suhair; Sijarina, Lorent; Yu, Edward; Thachuthara, Aoife Jones; Assouline, Avi; Souied, Osama; Hagel, Kimberly; Joseph, Kurian
Report
A Randomized Phase 2 Study of ATR Inhibition in Advanced PD-(L)1-Refractory Merkel Cell Carcinoma: The MATRiX Trial
Report
Window-of-opportunity Study of Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery: the MERCURY Trial
Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Recurrence after complete resection and selective use of adjuvant therapy for stage I through IIIMerkel cell carcinoma. Cancer. 2012 Jul 1;118(13):3311-20. doi: 10.1002/cncr.26626. Epub 2011 Nov 9.
D'Angelo SP, Bhatia S, Brohl AS, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbe C, Lewis KD, Linette GP, Milella M, Georges S, Shah P, Ellers-Lenz B, Bajars M, Guzel G, Nghiem PT. Avelumab in patients with previously treated metastaticMerkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. J Immunother Cancer. 2020 May;8(1):e000674. doi: 10.1136/jitc-2020-000674.
Hodgson NC.Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005 Jan 1;89(1):1-4. doi: 10.1002/jso.20167.
Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, Nghiem P. Clinical characteristics ofMerkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008 Mar;58(3):375-81. doi: 10.1016/j.jaad.2007.11.020.
Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, Wong SL. Analysis of Prognostic Factors from 9387Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Ann Surg Oncol. 2016 Oct;23(11):3564-3571. doi: 10.1245/s10434-016-5266-4. Epub 2016 May 19.
Becker JC.Merkel cell carcinoma. Ann Oncol. 2010 Oct;21 Suppl 7:vii81-5. doi: 10.1093/annonc/mdq366.
Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, Maas M, Mertz M, Veninga V, Bounova G, Broeks A, Beets-Tan RG, de Wijkerslooth TR, van Lent AU, Marsman HA, Nuijten E, Kok NF, Kuiper M, Verbeek WH, Kok M, Van Leerdam ME, Schumacher TN, Voest EE, Haanen JB. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6.
Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbe C, Delord JP, Dunn LA, Shinohara MM, Kulikauskas R, Chung CH, Martens UM, Ferris RL, Stein JE, Engle EL, Devriese LA, Lao CD, Gu J, Li B, Chen T, Barrows A, Horvath A, Taube JM, Nghiem P. Neoadjuvant Nivolumab for Patients With ResectableMerkel Cell Carcinoma in the CheckMate 358 Trial. J Clin Oncol. 2020 Aug 1;38(22):2476-2487. doi: 10.1200/JCO.20.00201. Epub 2020 Apr 23.
Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, Engelman JA, Dranoff G. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017 May;17(5):286-301. doi: 10.1038/nrc.2017.17. Epub 2017 Mar 24.
Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III
D'Angelo SP, Bhatia S, Brohl AS, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbe C, Lewis KD, Linette GP, Milella M, Georges S, Shah P, Ellers-Lenz B, Bajars M, Guzel G, Nghiem PT. Avelumab in patients with previously treated metastatic
Hodgson NC.
Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, Nghiem P. Clinical characteristics of
Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, Wong SL. Analysis of Prognostic Factors from 9387
Becker JC.
Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, Maas M, Mertz M, Veninga V, Bounova G, Broeks A, Beets-Tan RG, de Wijkerslooth TR, van Lent AU, Marsman HA, Nuijten E, Kok NF, Kuiper M, Verbeek WH, Kok M, Van Leerdam ME, Schumacher TN, Voest EE, Haanen JB. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6.
Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbe C, Delord JP, Dunn LA, Shinohara MM, Kulikauskas R, Chung CH, Martens UM, Ferris RL, Stein JE, Engle EL, Devriese LA, Lao CD, Gu J, Li B, Chen T, Barrows A, Horvath A, Taube JM, Nghiem P. Neoadjuvant Nivolumab for Patients With Resectable
Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, Engelman JA, Dranoff G. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017 May;17(5):286-301. doi: 10.1038/nrc.2017.17. Epub 2017 Mar 24.
Report
A Phase 2, Open Label, Single Arm Clinical Trial of Neoadjuvant Nivolumab and Relatlimab in Stage I To III Resectable Merkel Cell Carcinoma
Academic Journal
Academic Journal
Pompei, Veronica; Cecati, Monia; Serritelli, Emma Nicol; Gerini, Eleonora; Campagna, Roberto; Pozzi, Valentina; Van Haren, Matthijs J.; Martin, Nathaniel I.; Emanuelli, Monica; Sartini, Davide
Academic Journal
Erovic, Boban M.; Schmalwieser, Alois; Seemann, Rudolf; Schwabel, Florian; Grasl, Stefan; Janik, Stefan; Grasl, Matthaeus C.
Academic Journal
Chiara Mazziotta; Giulia Tonnini; Milena Oimo; Christian Felice Cervellera; Giada Badiale; Antoine Touzé; Elisa Assirelli; Simona Neri; Francesco Ursini; Maurizio Rossini; Giovanni Adami; Davide Gatti; Marcello Govoni; Mauro Tognon; Fernanda Martini; John Charles Rotondo
International Immunology. 37:625-634
검색 결과 제한하기
제한된 항목
[검색어] MERKEL, A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어